Barclays PLC boosted its stake in UiPath Inc. (NYSE:PATH - Free Report) by 55.2% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 968,036 shares of the healthcare company's stock after buying an additional 344,499 shares during the quarter. Barclays PLC owned approximately 0.17% of UiPath worth $16,039,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in PATH. Raymond James Financial Services Advisors Inc. lifted its position in UiPath by 3.8% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 40,993 shares of the healthcare company's stock worth $885,000 after buying an additional 1,506 shares in the last quarter. MetLife Investment Management LLC purchased a new stake in UiPath in the 1st quarter worth approximately $184,000. BlackRock Inc. lifted its position in UiPath by 1.9% in the 1st quarter. BlackRock Inc. now owns 5,316,635 shares of the healthcare company's stock worth $114,786,000 after buying an additional 99,242 shares in the last quarter. Dimensional Fund Advisors LP purchased a new stake in UiPath in the 1st quarter worth approximately $534,000. Finally, Canada Pension Plan Investment Board purchased a new stake in UiPath in the 1st quarter worth approximately $259,000. Hedge funds and other institutional investors own 59.04% of the company's stock.
Insider Buying and Selling at UiPath
In other UiPath news, CFO Ashim Gupta sold 40,000 shares of the stock in a transaction dated Monday, October 16th. The shares were sold at an average price of $16.10, for a total transaction of $644,000.00. Following the sale, the chief financial officer now owns 1,143,754 shares of the company's stock, valued at approximately $18,414,439.40. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, CFO Ashim Gupta sold 40,000 shares of the firm's stock in a transaction dated Monday, October 16th. The shares were sold at an average price of $16.10, for a total value of $644,000.00. Following the transaction, the chief financial officer now owns 1,143,754 shares of the company's stock, valued at approximately $18,414,439.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Rich Wong sold 100,000 shares of the firm's stock in a transaction dated Friday, September 22nd. The shares were sold at an average price of $16.38, for a total transaction of $1,638,000.00. Following the completion of the transaction, the director now directly owns 779,693 shares in the company, valued at approximately $12,771,371.34. The disclosure for this sale can be found here. In the last quarter, insiders sold 585,000 shares of company stock worth $11,989,650. 31.03% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
A number of equities research analysts have issued reports on the stock. DA Davidson increased their target price on shares of UiPath from $16.00 to $17.00 and gave the stock a "neutral" rating in a research report on Thursday, September 7th. Morgan Stanley raised their price target on shares of UiPath from $16.00 to $17.00 and gave the company an "equal weight" rating in a report on Friday, December 1st. JPMorgan Chase & Co. raised their price target on shares of UiPath from $19.00 to $22.00 and gave the company a "neutral" rating in a report on Friday, December 1st. Royal Bank of Canada raised their price target on shares of UiPath from $19.00 to $24.00 and gave the company a "sector perform" rating in a report on Friday, December 1st. Finally, Bank of America raised their price target on shares of UiPath from $20.00 to $22.00 in a report on Thursday, September 7th. Eight equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $21.96.
Check Out Our Latest Stock Analysis on PATH
UiPath Trading Up 0.0 %
Shares of PATH opened at $25.68 on Friday. The stock has a 50 day simple moving average of $18.72 and a 200-day simple moving average of $17.51. UiPath Inc. has a 1 year low of $10.98 and a 1 year high of $26.43. The stock has a market cap of $14.54 billion, a PE ratio of -91.71 and a beta of 0.86.
About UiPath
(
Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
